tiprankstipranks
Trending News
More News >
Medicenna Therapeutics Corp (MDNAF)
OTHER OTC:MDNAF
US Market
Advertisement

Medicenna Therapeutics Corp (MDNAF) Financial Statements

Compare
222 Followers

Medicenna Therapeutics Corp Financial Overview

Medicenna Therapeutics Corp's market cap is currently C$42.13M. The company's EPS TTM is $0.014600340000000002; its P/E ratio is ―; Medicenna Therapeutics Corp is scheduled to report earnings on June 26, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 25Mar 24Mar 23Mar 22Mar 21
Income Statement
Total RevenueC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross ProfitC$ -55.00KC$ -5.00KC$ -5.00KC$ -38.00KC$ -40.00K
Operating IncomeC$ -21.63MC$ -19.66MC$ -21.64MC$ -22.30MC$ -17.19M
EBITDAC$ -12.97MC$ -18.67MC$ -16.30MC$ -22.54MC$ -17.25M
Net IncomeC$ -11.80MC$ -25.47MC$ 1.55MC$ -22.65MC$ -17.18M
Balance Sheet
Cash & Short-Term InvestmentsC$ 24.84MC$ 16.98MC$ 33.60MC$ 20.54MC$ 40.38M
Total AssetsC$ 28.38MC$ 19.13MC$ 36.45MC$ 23.46MC$ 42.25M
Total DebtC$ 168.00KC$ 0.00C$ 0.00C$ 0.00C$ 34.00K
Net DebtC$ -24.67MC$ -16.98MC$ -33.60MC$ -20.54MC$ -30.34M
Total LiabilitiesC$ 9.29MC$ 13.94MC$ 6.96MC$ 2.62MC$ 4.11M
Stockholders' EquityC$ 19.09MC$ 5.19MC$ 29.49MC$ 20.84MC$ 38.15M
Cash Flow
Free Cash FlowC$ -16.52MC$ -16.26MC$ -12.66MC$ -23.58MC$ -15.31M
Operating Cash FlowC$ -16.49MC$ -16.26MC$ -12.66MC$ -23.58MC$ -15.31M
Investing Cash FlowC$ -33.00KC$ 0.00C$ -13.05MC$ 10.05MC$ 5.01M
Financing Cash FlowC$ 23.49MC$ 0.00C$ 24.76MC$ 3.88MC$ 18.26M
Currency in CAD

Medicenna Therapeutics Corp Earnings and Revenue History

Medicenna Therapeutics Corp Debt to Assets

Medicenna Therapeutics Corp Cash Flow

Medicenna Therapeutics Corp Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis